There
have been warnings about this for many years. They continue to fill
animals with antibiotics and to use antibiotics in inappropriate
ways; meanwhile the pharmaceutical industry has all but given up on
the search for new antibiotics because they can make more profit from
'lifestyle drugs'.
Superbug
scenario: Antibiotic resistance will be ‘catastrophe’ on par with
terrorism
Antibiotic-resistant
superbugs will push medical science back to the 19th century, with
people dying of minor infections says Britain’s top health
official.
RT,
13
March, 2013
Dame
Sally Davies, chief medical officer for England, said action is
urgently needed to fight antibiotic and antimicrobial resistance and
that new drugs must be developed to treat new mutating infections.
She
warned that if nothing is done to reverse the situation Britain would
face an apocalyptic scenario with “a health system not dissimilar
from the 19th century.”
Two
months ago Dame Davies warned British legislators that antibiotic
resistance should be added to the UK’s national risk register. The
register was set up in 2008 to advise the public and businesses on
national emergencies that the UK could face in the next five years.
The
highest risks currently on the list include a catastrophic terrorist
attack, a flu pandemic and coastal flooding, as was seen during the
1952 North Sea flood, the last time a national emergency was called
in the UK.
As
bacterial infections evolve into ‘superbugs’ like MRSA, which are
resistant to existing drugs, more must be done discover new
antibiotics. Only a few antibiotics have been discovered in the last
few decades.
“Antimicrobial
resistance poses a catastrophic threat. If we don’t act now any one
of us could go into hospital in 20 years for minor surgery and die
because of an ordinary infection that can’t be treated by
antibiotics, And routine operations like hip replacements or organ
transplants could be deadly because of the risk of infection,”
Davies told reporters as she published her report on infectious
disease.
Untreatable
superbugs are popping up all over the world. A superbug with a
mutation known as NDM 1, which was first detected in India, has now
turned up in most other countries. There have also been cases of a
totally drug-resistant form of tuberculosis and the World Health
Organization (WHO) said an untreatable form of gonorrhea was
spreading round the world.
MRSA,
one of the best known superbugs, is estimated to kill 19,000 people
every year in the US and a similar number in Europe, far more than
HIV and AIDS.
Davies’s
research has been welcomed by scientists and medical professionals.
“There
are an increasing number of infections for which there are virtually
no therapeutic options. And we desperately need new discovery,
research and development,” Laura Piddock, professor of microbiology
at Birmingham University and director of Antibiotic Action, a
campaign group, told Reuters.
Davies
has called for better cooperation between the pharmaceutical and
healthcare industries in order to focus on developing new antibiotics
as well as preserving the arsenal of existing ones.
She
also called on governments to take the threat seriously and suggested
the WHO and the G8 encourage more innovation in the field of
antibiotics.
“Over
the past two decades there has been a discovery void around
antibiotics, meaning diseases have evolved faster than the drugs to
treat them,” said Davies.
Although
a small number of new individual drugs are being developed, no new
classes of antibiotics have been developed since 1987. The main
reason, explains Davies, is that is there little money to be made in
developing new courses of antibiotics.
She
added that more effort should be made by doctors to prescribe
antibiotics only when needed and that hygiene should be improved in
hospitals to make sure infections were kept to a minimum.
Keith
Ridge, the UK government’s chief pharmaceutical officer, said that
although the number of antibiotics prescribed in hospital had fallen,
there still needed to be tighter control of antibiotic prescriptions
in GP’s surgeries.
“We
need new ways to kill resistant bacteria or reduce their carriage of
resistant genes. Novel approaches that might have appeared
unrealistic a few years ago need to be explored,” Professor
Christopher Thomas, professor of molecular genetics at the University
of Birmingham, told the Independent.
The
WHO made drug resistance the focus of its 2011 World Health Day,
warning the
“world
is heading towards a post-antibiotic era, in which many common
infections will no longer have a cure and, once again, kill
unabated.”
No comments:
Post a Comment
Note: only a member of this blog may post a comment.